Effects of breast milk on Behçet’s disease clinical features

Background/aim: The etiology of Behçet’s disease (BD) is not clearly known, however, abnormal activity in T helper (Th) 1, Th 17, and regulatory T cells (Treg) has critical importance in pathogenesis. It has been shown that the intestinal microbiome can be effective in the modulation of these immune abnormalities in BD patients. Breastfeeding increases the maturation of the infant’s intestinal permeability by affecting the newborn’s immature intestinal microbiome and metagenome. We aimed to examine the effects of breastfeeding on disease related symptoms, organ involvements and course of the disease in BD patients. Materials and methods: This study was designed as a cross-sectional study in Ankara City Hospital rheumatology clinic between December 2021 and March 2022. Patients who were diagnosed with BD by meeting the criteria of the ‘International Study Group’ and whose information we could access by agreeing to participate in the study were enrolled. The mothers of the patients were also contacted and asked whether these patients were breastfed, the duration of breastfeeding, and the mode of birth. Demographic and clinical data of the patients, comorbid diseases, and drugs used for BD were collected from the records in the hospital database. The presence of sacroiliitis in patients was evaluated with sacroiliac X-ray and/or magnetic resonance imaging (MRI), which was requested because of low back pain symptoms and only patients with previous sacroiliac imaging for low back pain were included in the study. BD-related organ damage was measured by the Vasculitis Damage Index (VDI) and Behçet’s syndrome Overall Damage Index (BODI) scores. Results: A total of 304 patients were included in the study. The percentage of patients who were reported to have ever breastfed (median duration (IQR): 12(12) months, 33.5% < 6 months, 66.4% ≥ 6 months, and 59.6% ≥ 12 months) is 92%. When the breastfed and nonbreastfed patients were compared, 6.8% of the breastfed patients needed TNF-i against 18.2% of the nonbreastfed patients (p = 0.052). While the rate of having at least one comorbidity was 26.4% for those who were breastfed, this rate was 50% for those who had never been breastfed. When the organ and system involvements of the patients were compared, the incidence of sacroiliitis was statistically significantly higher in the nonbreastfed group (p = 0.025). Patients who were breastfed for less than 6 months were diagnosed with BD at an earlier age than those who were breastfed for more than 6 months, and those who were breastfed for less than 12 months compared to those who were breastfed for more than 12 months (respectively, p = 0.039, p = 0.035). Conclusion: Our results imply that history of breastfeeding may have some positive effects on the course of the disease in BD patients. Key words: Behçet’s disease, breastfeeding, innate immunity, sacroiliitis

Anahtar Kelime: Behçet’s disease breastfeeding innate immunity sacroiliitis

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Cho SB, Cho S, Bang D. New insights in the clinical understanding of Behçet’s disease. Yonsei Medical Journal 2012; 53 (1): 35-42. https://doi.org/10.1016/j.rdc.2013.02.010
2. Ortiz-Fernández L, Sawalha AH. Genetics of Behçet’s Disease: Functional Genetic Analysis and Estimating Disease Heritability. Frontiers in Medicine 2021; 8:625710. https://doi. org/10.3389/fmed.2021.625710
3. Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A et al. Behçet’s disease physiopathology: a contemporary review. Auto- Immunity Highlights 2016; 7(1):4. https://doi. org/10.1007/s13317-016-0074-1
4. Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behçet’s disease: A comprehensive review. Journal of Autoimmunity 2015; 64:137-148. https://doi.org/10.1016/j. jaut.2015.08.013
5. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331(6015):337-341. https:// doi.org/10.1126/science.1198469
6. Kamada N, Seo SU, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nature Reviews Immunology 2013; 13(5):321-335. https://doi. org/10.1038/nri3430
7. Ye Z, Zhang N, Wu C, Zhang X, Wang Q et al. A metagenomic study of the gut microbiome in Behcet’s disease. Microbiome 2018; 6(1): 135. https://doi.org/10.1186/s40168-018-0520-6
8. Newburg DS. Innate immunity and human milk. The Journal of Nutrition 2005; 135(5):1308-1312. https://doi.org/10.1093/ jn/135.5.1308
9. Victora CG, Bahl R, Barros AJ, França GV, Horton S et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 2016; 387(10017): 475-490. https:// doi.org/10.1016/S0140-6736(15)01024-7
10. Schei K, Avershina E, Øien T, Rudi K, Follestad T et al. Early gut mycobiota and mother-offspring transfer. Microbiome 2017; 5(1): 107. https://doi.org/10.1186/s40168-017-0319-x
11. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatric Research 2007; 61(1): 2-8. https://doi.org/10.1203/01. pdr.0000250274.68571.18
12. Macpherson AJ, de Agüero MG, Ganal-Vonarburg SC. How nutrition and the maternal microbiota shape the neonatal immune system. Nature Reviews Immunology 2017; 17(8): 508-517. https://doi.org/10.1038/nri.2017.58
13. Kelishadi R, Farajian S. The protective effects of breastfeeding on chronic non-communicable diseases in adulthood: A review of evidence. Advanced Biomedical Research 2014; 3:3. https://doi.org/10.4103/2277-9175.124629
14. Brahm P, Valdés V. The benefits of breastfeeding and associated risks of replacement with baby formulas. Revista Chilena de Pediatria 2017; 88(1): 7-14. https://doi.org/10.4067/S0370- 41062017000100001
15. Hyrich KL, Baildam E, Pickford H, Chieng A, Davidson JE et al. Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis. Archives of Disease in Childhood 2016; 101(4): 348-351. https://doi. org/10.1136/archdischild-2014-308117
16. Montoya J, Matta NB, Suchon P, Guzian MC, Lambert NC et al. Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective study. Annals of the Rheumatic Disease 2016; 75(5): 879-882. https:// doi.org/10.1136/annrheumdis-2015-208187
17. Binns C, Lee M, Low WY. The Long-Term Public Health Benefits of Breastfeeding. Asia-Pacific Journal of Public Health 2016; 28(1): 7-14. https://doi.org/10.1177/1010539515624964
18. Klement E, Cohen RV, Boxman J, Joseph A, Reif S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. The American Journal of Clinical Nutrition 2004; 80(5): 1342-1352. https://doi.org/10.1093/ajcn/80.5.1342
19. Chen H, Wang J, Zhou W, Yin H, Wang M. Breastfeeding and Risk of Rheumatoid Arthritis: A Systematic Review and Metaanalysis. Journal of Rheumatology 2015; 42(9): 1563- 1569. https://doi.org/10.3899/jrheum.150195
20. Vieira Borba V, Sharif K, Shoenfeld Y. Breastfeeding and autoimmunity: Programing health from the beginning. American Journal of Reproductive Immunology 2018; 79(1). https://doi.org/10.1111/aji.12778
21. Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 1990; 335(8697): 1078-1780
22. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis and Rheumatism 1997; 40(2): 371-380. https://doi.org/10.1002/art.1780400222
23. Piga M, Floris A, Espinosa G, Serpa Pinto L, Kougkas et al. Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI). RMD Open 2020; 6(2). https://doi.org/10.1136/rmdopen-2020-001192
24. Moossavi S, Miliku K, Sepehri S, Khafipour E, Azad MB. The Prebiotic and Probiotic Properties of Human Milk: Implications for Infant Immune Development and Pediatric Asthma. Frontiers in Pediatrics 2018; 6: 197. https://doi. org/10.3389/fped.2018.00197
25. Hunt KM, Foster JA, Forney LJ, Schütte UM, Beck DL et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 2011; 6(6): e21313. https://doi.org/10.1371/journal.pone.0021313
26. Collado MC, Delgado S, Maldonado A, Rodríguez JM. Assessment of the bacterial diversity of breast milk of healthy women by quantitative real-time PCR. Letters in Applied Microbiology 2009; 48(5): 523-528. https://doi.org/10.1111/ j.1472-765X.2009.02567.x
27. Breastfeeding and the use of human milk. Pediatrics 2012; 129(3): e827-841. https://doi.org/10.1542/peds.2011-3552
28. Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet 2001; 357(9254): 413-419. https://doi.org/10.1016/ S0140-6736(00)04004-6
29. Ip S, Chung M, Raman G, Chew P, Magula N et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evidence Report/Technology Assessment 2007 (153): 1-186
30. Jones ME, Swerdlow AJ, Gill LE, Goldacre MJ. Pre-natal and early life risk factors for childhood onset diabetes mellitus: a record linkage study. International Journal of Epidemiology 1998; 27(3): 444-449. https://doi.org/10.1093/ije/27.3.444
31. Miliku K, Azad MB. Breastfeeding and the Developmental Origins of Asthma: Current Evidence, Possible Mechanisms, and Future Research Priorities. Nutrients 2018; 10(8) 995. https://doi.org/10.3390/nu10080995
32. Julia V, Macia L, Dombrowicz D. The impact of diet on asthma and allergic diseases. Nature Reviews Immunology 2015; 15(5): 308-322. https://doi.org/10.1038/nri3830
33. Cho SB, Lee JH, Ahn KJ, Bae BG, Kim T et al. Anti-cyclic citrullinated peptide antibodies and joint involvement in Behçet’s disease. Yonsei Medical Journal 2012; 53(4):759-764. https://doi.org/10.3349/ymj.2012.53.4.759
34. Chang HK, Lee DH, Jung SM, Choi SJ, Kim J et al. The comparison between Behçet’s disease and spondyloarthritides: does Behçet’s disease belong to the spondyloarthropathy complex? Journal of Korean Medical Science 2002; 17(4):524- 529. https://doi.org/10.3346/jkms.2002.17.4.524
35. Yazici H, Tuzlaci M, Yurdakul S. A controlled survey of sacroiliitis in Behcet’s disease. Annals of the Rheumatic Diseases 1981; 40(6): 558-559. https://doi.org/10.1136/ ard.40.6.558
36. Van Praet L, Jans L, Carron P, Jacques P, Glorieus E et al. Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort. Annals of the Rheumatic Diseases 2014; 73(6): 1186-9 https://doi.org/10.1136/ annrheumdis-2013-203854
37. Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Behçet’s disease: analysis of published data on 369 patients. Seminars in Arthritis and Rheumatism 2011; 41(1): 61-70. https://doi.org/10.1016/j.semarthrit.2010.09.002
38. Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H et al. Expression of Th-17 and RORγt mRNA in Behçet’s Disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2011; 17(4): Cr227-234. https://doi.org/10.12659/msm.881720
39. Zhu Y, Qiu Y, Yu H, Yi S, Su W et al. Aberrant DNA methylation of GATA binding protein 3 (GATA3), interleukin-4 (IL-4), and transforming growth factor-β (TGF-β) promoters in Behcet’s disease. Oncotarget 2017; 8(38):64263-64272. https://doi. org/10.18632/oncotarget.19500
40. Ma X, Wang X, Zheng G, Tan G, Zhou F et al. Critical Role of Gut Microbiota and Epigenetic Factors in the Pathogenesis of Behçet’s Disease. Frontiers in Cell and Developmental Biology 2021; 9:719235. https://doi.org/10.3389/fcell.2021.719235
41. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunology 2007; 8(9): 942-949. https://doi.org/10.1038/ni1496

APA	Konak H, erden a, Armagan B, Güven S, APAYDIN H, Akyüz Dağlı P, uzun y, Kaygısız M, kucuksahin o, Omma A (2023). Effects of breast milk on Behçet’s disease clinical features. , 121 - 129. 10.55730/1300-0144.5565
Chicago	Konak Hatice Ecem,erden abdulsamet,Armagan Berkan,Güven Serdar Can,APAYDIN HAKAN,Akyüz Dağlı Pınar,uzun yağnur,Kaygısız Merve,kucuksahin orhan,Omma Ahmet Effects of breast milk on Behçet’s disease clinical features. (2023): 121 - 129. 10.55730/1300-0144.5565
MLA	Konak Hatice Ecem,erden abdulsamet,Armagan Berkan,Güven Serdar Can,APAYDIN HAKAN,Akyüz Dağlı Pınar,uzun yağnur,Kaygısız Merve,kucuksahin orhan,Omma Ahmet Effects of breast milk on Behçet’s disease clinical features. , 2023, ss.121 - 129. 10.55730/1300-0144.5565
AMA	Konak H,erden a,Armagan B,Güven S,APAYDIN H,Akyüz Dağlı P,uzun y,Kaygısız M,kucuksahin o,Omma A Effects of breast milk on Behçet’s disease clinical features. . 2023; 121 - 129. 10.55730/1300-0144.5565
Vancouver	Konak H,erden a,Armagan B,Güven S,APAYDIN H,Akyüz Dağlı P,uzun y,Kaygısız M,kucuksahin o,Omma A Effects of breast milk on Behçet’s disease clinical features. . 2023; 121 - 129. 10.55730/1300-0144.5565
IEEE	Konak H,erden a,Armagan B,Güven S,APAYDIN H,Akyüz Dağlı P,uzun y,Kaygısız M,kucuksahin o,Omma A "Effects of breast milk on Behçet’s disease clinical features." , ss.121 - 129, 2023. 10.55730/1300-0144.5565
ISNAD	Konak, Hatice Ecem vd. "Effects of breast milk on Behçet’s disease clinical features". (2023), 121-129. https://doi.org/10.55730/1300-0144.5565

APA	Konak H, erden a, Armagan B, Güven S, APAYDIN H, Akyüz Dağlı P, uzun y, Kaygısız M, kucuksahin o, Omma A (2023). Effects of breast milk on Behçet’s disease clinical features. Turkish Journal of Medical Sciences, 53(1), 121 - 129. 10.55730/1300-0144.5565
Chicago	Konak Hatice Ecem,erden abdulsamet,Armagan Berkan,Güven Serdar Can,APAYDIN HAKAN,Akyüz Dağlı Pınar,uzun yağnur,Kaygısız Merve,kucuksahin orhan,Omma Ahmet Effects of breast milk on Behçet’s disease clinical features. Turkish Journal of Medical Sciences 53, no.1 (2023): 121 - 129. 10.55730/1300-0144.5565
MLA	Konak Hatice Ecem,erden abdulsamet,Armagan Berkan,Güven Serdar Can,APAYDIN HAKAN,Akyüz Dağlı Pınar,uzun yağnur,Kaygısız Merve,kucuksahin orhan,Omma Ahmet Effects of breast milk on Behçet’s disease clinical features. Turkish Journal of Medical Sciences, vol.53, no.1, 2023, ss.121 - 129. 10.55730/1300-0144.5565
AMA	Konak H,erden a,Armagan B,Güven S,APAYDIN H,Akyüz Dağlı P,uzun y,Kaygısız M,kucuksahin o,Omma A Effects of breast milk on Behçet’s disease clinical features. Turkish Journal of Medical Sciences. 2023; 53(1): 121 - 129. 10.55730/1300-0144.5565
Vancouver	Konak H,erden a,Armagan B,Güven S,APAYDIN H,Akyüz Dağlı P,uzun y,Kaygısız M,kucuksahin o,Omma A Effects of breast milk on Behçet’s disease clinical features. Turkish Journal of Medical Sciences. 2023; 53(1): 121 - 129. 10.55730/1300-0144.5565
IEEE	Konak H,erden a,Armagan B,Güven S,APAYDIN H,Akyüz Dağlı P,uzun y,Kaygısız M,kucuksahin o,Omma A "Effects of breast milk on Behçet’s disease clinical features." Turkish Journal of Medical Sciences, 53, ss.121 - 129, 2023. 10.55730/1300-0144.5565
ISNAD	Konak, Hatice Ecem vd. "Effects of breast milk on Behçet’s disease clinical features". Turkish Journal of Medical Sciences 53/1 (2023), 121-129. https://doi.org/10.55730/1300-0144.5565